| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |